Zeldes & Haeggquist represents individual and institutional investors recover losses from corporate securities fraud.
If you have lost money investing in the stocks or bonds of a publicly-traded company, and your loss was caused by fraud at the company, you have the right to file a lawsuit under the federal securities laws to attempt to recover your loss.
We counsel investors on how to maximize their recover, either by bringing a class action, or where appropriate, by bringing an individual or "opt out" case.
Our partner, Amber Eck, has worked for over 12 years on a wide range of securities fraud cases across the United States, recovering millions of dollars for her clients.
If you would like to discuss your rights under the federal securities laws, please contact Amber Eck for a free consultation.
CURRENT SECURITIES CLASS ACTIONS:
K-V Pharmaceuticals.
On October 19, 2011, Zeldes & Haeggquist, LLP and Scott + Scott LLP filed a securities class action for violations of the anti-fraud provisions of the federal securities laws against K-V Pharmaceutical Company on behalf of all purchasers of the publicly traded securities of K-V between February 14, 2011 and April 4, 2011 (the “Class Period”), who were damaged thereby. The Complaint alleges that K-V and certain officers and directors made misrepresentations concerning Makena -- a hormone medication prescribed to pregnant women to reduce the risk of preterm birth in women who have delivered a baby preterm in the past. For more information about the case or your rights as a shareholder, please click here to Join this Action, Contact us view our Press Release or view our Complaint.
CardioNet, Inc.
Zeldes & Haeggquist, LLP are co-counsel in a securities class action that has been filed in San Diego Superior Court against CardioNet, Inc. on behalf of all persons and entities that purchased or acquired CardioNet's common stock pursuant or traceable to the Registration Statement and Prospectuses issued in connection with its $83 million initial public offering ("IPO") on March 5, 2008, and/or its $152 million secondary offering on August 6, 2008, seeking strict liability Section 11 remedies under the Securities Act of 1933. On September 2, 2011, the Court denied CardioNet's motion to dismiss, finding that "at the pleading stage plaintiff has sufficiently pled a material misrepresentation or omission in the registration statements." See "CardioNet Can't Escape IPO Class Action," Securities Law 360 (Sept. 2, 2011).
United Online (UNTD)
Zeldes & Haeggquist, LLP s investigating a possible securities fraud class action lawsuit against United Online (UNTD) involving misleading and aggressive internet sales tactics that harmed consumers and were criticized in a Senate Report. If you purchased United Online stock between May 1, 2007 and November 17, 2009 and would like more information about your rights as a shareholder, please click here to Join this Action, Contact us and/or view our Press Release.
